We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FTC will allow biotechnology company Genzyme’s proposed $1 billion acquisition of Ilex Oncology to proceed as long as the companies surrender the rights to a key organ transplant drug, according to the terms of a consent order.
The U.S. Pharmacopeia (USP) should not expand the number of drug categories and classes in its final draft guidelines for Medicare drug benefit formularies, according to a coalition of employers, health insurers, pharmacists and pharmaceutical benefit managers (PBMs).
Aiming to change the tenor of the drug pricing debate, GlaxoSmithKline (GSK) has directed its 9,000 pharmaceutical sales reps to deliver at least one “value of medicines” presentation to a community group by end of the year, according to a top company executive.
One of the initial strategies that Applied Digital Solutions will use to market its recently approved VeriChip will be as a gateway for medical device information, company officials said during an Oct. 13 conference call.
Moving human clinical trials to low-cost countries could save GlaxoSmithKline (GSK) more than $200 million annually in R&D costs, according to the drug giant’s top executive.
In the latest move by a state to lower drug costs, West Virginia lawmakers overwhelmingly passed a bill Saturday that calls on the brand industry to establish a drug discount clearinghouse that could force companies to set their prices at lower rates established by federal or Canadian programs.
As the call for the reimportation of Rx drugs grows louder on Capitol Hill and in state capitals, the No. 2 drugmaker and the industry’s trade association are embarking on campaigns to change the tenor of the debate.
Minnesota Gov. Tim Pawlenty wants the board that oversees investment of state pension funds to use its standing as a Pfizer shareholder to pressure the company to change its drug prices.
FDA Commissioner Mark McClellan has asked Canadian authorities to more aggressively regulate internet pharmacies in the wake of a Minnesota study that found safety violations at several sites.
The average annual percentage growth in the amount Americans spend on Rx drugs is expected to continue to decline over the next decade, according to a report released yesterday by the Centers for Medicare & Medicaid Services (CMS).